Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.54 |
| ▸ | CA12 | O43570 | 3/20 | 0.46 |
| ▸ | CA1 | P00915 | 3/20 | 0.46 |
| ▸ | CA2 | P00918 | 3/20 | 0.46 |
| ▸ | CA4 | P22748 | 3/20 | 0.46 |
| ▸ | CA7 | P43166 | 3/20 | 0.46 |
| ▸ | CA9 | Q16790 | 3/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | HMGB1 | P09429 | 2/20 | 0.46 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | NAPRT | Q6XQN6 | 2/20 | 0.46 |
| ▸ | CA6 | P23280 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29404318 | 1.00 | ALDH1A1 (0.54) | ALDH1A1ALOX15CA12CA1CA2 | |
| Phosphine SCHEMBL22446073 | 0.98 | ALDH1A1 (0.52) | ALDH1A1ALOX15CA12CA1CA2 | |
| SCHEMBL5597248 | 0.98 | ALDH1A1 (0.52) | ALDH1A1ALOX15CA12CA1CA2 | |
| Bromide SCHEMBL3660816 | 0.98 | ALDH1A1 (0.52) | ALDH1A1ALOX15CA12CA1CA2 | |
| SCHEMBL31553567 | 0.98 | ALDH1A1 (0.52) | ALDH1A1ALOX15CA12CA1CA2 | |
| Ammonia Solution, Strong SCHEMBL31339444 | 0.98 | ALDH1A1 (0.52) | ALDH1A1ALOX15CA12CA1CA2 | |
| SCHEMBL7564286 | 0.96 | ALDH1A1 (0.54) | ALDH1A1ALOX15CA12CA1CA2 | |
| SCHEMBL31003867 | 0.92 | ALDH1A1 (0.46) | ALDH1A1ALOX15CA12CA1CA2 | |
| SCHEMBL7260802 | 0.89 | ALDH1A1 (0.62) | ALDH1A1ALOX15CA12CA1CA2 | |
| SCHEMBL1524729 | 0.87 | CYP3A4 (0.46) | ALDH1A1ALOX15CA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 809 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12612343-B2 | PSMA binder and use thereof | Shiya Pharmaceutical, Inc (CN) | 2026-04-28 | — | — | US | claimed |
| WO-2025106936-A1 | POLY(METH)ACRYLIMIDE MATERIALS WITH ENHANCED THERMOMECHANICAL PROPERTIES | GENCORES, INC. (US) | 2025-05-22 | — | — | WO | claimed |
| CN-115372341-B | Bioluminescence detection system of bacterial cell wall neopeptidoglycan constructed by D-lysine derivative and application method | 西北工业大学深圳研究院 | 2025-04-25 | — | — | CN | claimed |
| CN-119874466-A | N, N-dimethylamide compound and synthesis method thereof | 海南大学 | 2025-04-25 | — | — | CN | claimed |
| US-20250122269-A1 | SELECTIVE REDUCTION OF ANTIBODIES | ABBVIE INC (US) | 2025-04-17 | — | — | US | claimed |
| US-20250073692-A1 | PROCESS FOR PREPARING LINEAR ALPHA-OLEFIN BY OLIGOMERIZATION OF ETHYLENE | NANJING CHEMISTRY NEW ENERGY TECHNOLOGY CO., LTD. (CN) | 2025-03-06 | — | — | US | claimed |
| CN-119488608-A | Engineering bispecific antibody coupling drug and preparation method and application thereof | 上海药明合联生物技术有限公司 | 2025-02-21 | — | — | CN | claimed |
| CN-118927721-A | Breathable garment fabric and preparation method thereof | 雄县广宇服装有限公司 | 2024-11-12 | — | — | CN | claimed |
| CN-118359573-A | Coumarin-based endoplasmic reticulum targeting fluorescent probe for detecting nitrosyl hydrogen and preparation method and application thereof | 南京林业大学 | 2024-07-19 | — | — | CN | claimed |
| US-20240216521-A1 | METHODS OF PREPARING CELL-BINDING AGENT-DRUG CONJUGATES | IMMUNOGEN INC (US) | 2024-07-04 | — | — | US | claimed |
| US-6184428-B1 | USING A SUPPORTED HETEROGENOUS CATALYST (2-DIPHENYLPHOSPHINO-BENZOIC ACID, NICKEL CHLORIDE HYDRATE AND SODIUM TETRAPHENYL-BORATE) SLURRY; CONTINUOUS PROCESSING; HIGHLY ACTIVE TO PRODUCE ALPHA-OLEFINS OF NARROW MOLECULAR WEIGHT DISTRIBUTION | SAUDI BASIC INDUSTRIES CORPORATION (SA) | 2001-02-06 | — | — | US | claimed |
| US-6180831-B1 | REACTING 1,2-OXIRANES WITH CARBON MONOXIDE AND HYDROGEN IN PRESENCE OF COBALT TRANSITION METAL COMPOUND CATALYST, WHEREIN SAID COBALT TRANSITION METAL COMPOUND IS MODIFIED WITH PHOSPHORUS-OXYGEN LIGAND OR NITROGEN-OXYGEN LIGAND | DEGUSSA-HULS AG (DE) | 2001-01-30 | — | — | US | claimed |
| EP-1066298-A1 | PREPARATION OF PHOSPHINE LIGANDS | Chirotech Technology Limited (GB) | 2001-01-10 | — | — | EP | claimed |
| WO-1999051614-A1 | PREPARATION OF PHOSPHINE LIGANDS | CHIROTECH TECHNOLOGY LIMITED (GB) | 1999-10-14 | — | — | WO | claimed |
| EP-0177999-B1 | ETHYLENE OLIGOMERIZATION PROCESS CARRIED OUT IN A DIOL-BASED SOLVENT CONTAINING MONOHYDRIC ALCOHOL OR WATER | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1989-01-18 | — | — | EP | claimed |
| EP-0177999-A1 | Ethylene oligomerization process carried out in a diol-based solvent containing monohydric alcohol or water | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1986-04-16 | — | — | EP | claimed |
| US-4528416-A | Ethylene oligomerization process carried out in a monohydric/dihydric alcohol solvent mixture | SHELL OIL COMPANY (US) | 1985-07-09 | — | — | US | claimed |
| EP-0033553-B1 | NICKEL COMPLEXES IN DIOL SOLVENTS AND THEIR USE AS PART OF A CATALYST IN THE OLIGOMERIZATION OF ETHYLENE | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1984-06-06 | — | — | EP | claimed |
| EP-0033553-A2 | Nickel complexes in diol solvents and their use as part of a catalyst in the oligomerization of ethylene | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1981-08-12 | — | — | EP | claimed |
| US-4260844-A | Nickel complexes in diol solvents and their use as oligomerization catalyst precursors | SHELL OIL COMPANY (US) | 1981-04-07 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250122269-A1 | SELECTIVE REDUCTION OF ANTIBODIES | CD2BP2, CD22, CD2 | ALDH1A1 1260/4885ALOX15 4404/4885CA12 307/4885 |
| US-20240216521-A1 | METHODS OF PREPARING CELL-BINDING AGENT-DRUG CONJUGATES | EPCAM, CD2BP2, XPA | ALDH1A1 1529/4885ALOX15 3288/4885CA12 155/4885 |
| US-12612343-B2 | PSMA binder and use thereof | KLK3, AR, PSMA1 | ALDH1A1 524/4885ALOX15 4736/4885CA12 46/4885 |
| US-20250073692-A1 | PROCESS FOR PREPARING LINEAR ALPHA-OLEFIN BY OLIGOMERIZATION OF ETHYLENE | EDF1, ELL, EEF1D | ALDH1A1 3709/4885ALOX15 464/4885CA12 3943/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.